Last reviewed · How we verify
Blood sample collection
Blood sample collection is a diagnostic procedure, not a drug with a pharmacological mechanism of action.
At a glance
| Generic name | Blood sample collection |
|---|---|
| Sponsor | Emergent BioSolutions |
| Modality | Biologic |
| Phase | FDA-approved |
Mechanism of action
Blood sample collection is a laboratory technique used to obtain blood specimens from patients for diagnostic testing, analysis, and medical evaluation. It is a procedural service rather than a therapeutic or pharmaceutical intervention, and does not exert any direct pharmacological effect on the body.
Approved indications
Common side effects
Key clinical trials
- Collection of Blood From Patients With Prostate Cancer
- Screening and Multiple Intervention on Lung Epidemics (PHASE2)
- Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer (PHASE2)
- Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial (PHASE2)
- Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial (PHASE1)
- Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma (PHASE3)
- Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm (PHASE2)
- Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Blood sample collection CI brief — competitive landscape report
- Blood sample collection updates RSS · CI watch RSS
- Emergent BioSolutions portfolio CI